Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chenglian Technology

Explore full profile

High-tech enterprise that focuses on the digital manufacturing of the whole process of dentistry

ChinaFounded 2017Health Tech & Medtech
Valuation $250–500M Last recorded · 2025
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chenglian Technology and the history behind them.

About Chenglian Technology

Nanjing Chamlion specializes in Selective Laser Melting (SLM) metal 3D printing technology, focusing primarily on the medical sector. The company offers advanced 3D printing equipment and services that are widely used for producing dental crowns, bridges, supports, and implants. With a strong presence in global markets including the United States, Canada, Italy, and South Korea, Chamlion serves over 1,000 users who praise its high-quality and efficient solutions. The company's dual laser systems significantly enhance accuracy and efficiency, while its proprietary software allows for deep customization to meet specific customer needs. Chamlion operates on a business model that combines equipment sales and printing services, generating revenue through both hardware and service offerings. The company is a national high-tech enterprise, incubated by the Jiangsu Institute of 3D Intelligent Manufacturing and the Additive Manufacturing Institute of Nanjing University of Aeronautics and Astronautics. Chamlion's technology boasts nearly 100% material utilization and requires minimal human intervention, making it cost-effective and easy to maintain.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
China
Employees
36
Open positions
None listed
Dealroom signal
34.1/100
Industry
Health, Engineering and Manufacturing Equipment
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing May 2025 $28M $481M ShenZhen GTJA Investment Group · Guochen Venture Capital ↗
SERIES BOther financing Apr 2023 $32M $130M Zhencheng Capital · Vertex Ventures China · 3H Health Investment ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Chenglian Technology website traffic

Latest recorded traffic for Chenglian Technology is 350 monthly website visits, up 288.9% over the last three months. Chenglian Technology's team grew 2.9% over the past year.

Latest monthly visits350 3-month web change+288.9% 1-year team growth+2.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Rivermark MedicalMinimally invasive treatment for Benign Prostatic Hyperplasia, restoring urinary function and enabling early return to daily life Milwaukee, United States Operational 17 $55M $150M
Core Medical TechnologySpecializes in smart wear and smart medical technology solutions Ningbo, China Operational
AvivomedDeveloping and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases Minneapolis, United States Operational
AdriakaimVagus nerve stimulation device for myocardial infarction patients Tokyo, Japan Operational
May HealthA medical device company developing a minimally invasive ablation technology designed to restore ovulation in women with PCOS-related infertility Paris, France Operational
Micro Medical SolutionsProvides practical, successful new answers to some of the most pressing unmet needs in microvascular intervention Wilmington, United States Operational
Noctrix HealthEarly-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness Pleasanton, United States Acquired
Saluda MedicalDedicated to improving the lives of people by providing personalized, responsive, and efficient neuromodulation therapy (spinal cord stimulation ) Sydney, Australia Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Zhencheng Investment
  • 3H Health Investment
  • Zhencheng Capital
  • Vertex Ventures China
  • ShenZhen GTJA Investment Group
  • Guochen Venture Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇨🇳 China47.1%
🇺🇸 United States11.8%
🇩🇪 Germany5.9%
🇨🇦 Canada5.9%
🇫🇷 France5.9%
Top 5 of 9 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chenglian Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chenglian Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.